Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Raquel Salazar-Méndez, Taygan Yilmaz & Miguel Cordero-Coma. (2016) Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development. Expert Opinion on Investigational Drugs 25:2, pages 195-214.
Read now
Read now
Alfredo Adán, Marina Mesquida & Victor Llorenç. (2013) Biologic drugs in noninfectious uveitis: an update. Expert Review of Ophthalmology 8:5, pages 501-516.
Read now
Read now
Bertrand Pilly, Greg Heath, Patrizia Tschuor, Susan Lightman & Richard P Gale. (2013) Overview and recent developments in the medical management of paediatric uveitis. Expert Opinion on Pharmacotherapy 14:13, pages 1787-1795.
Read now
Read now
Luca Cantarini, Gabriele Simonini, Bruno Frediani, Ilaria Pagnini, Mauro Galeazzi & Rolando Cimaz. (2012) Treatment strategies for childhood noninfectious chronic uveitis: an update. Expert Opinion on Investigational Drugs 21:1, pages 1-6.
Read now
Read now
Articles from other publishers (10)
Laura E.M. Eurelings, Tom O.A.R. Missotten, Mirjam E.J. van Velthoven, Paul L.A. van Daele, Jan A.M. van Laar, P. Martin van Hagen, Alberta A.H.J. Thiadens & Saskia M. Rombach. (2022) Long-Term Follow-up of Patients With Uveitis Treated With Adalimumab: Response Rates and Reasons for Discontinuation of Therapy. American Journal of Ophthalmology 240, pages 194-204.
Crossref
Crossref
Archana Airody, Greg Heath, Susan Lightman & Richard Gale. (2015) Non-Infectious Uveitis: Optimising the Therapeutic Response. Drugs 76:1, pages 27-39.
Crossref
Crossref
Jennifer L. Kielczewski & Rachel R. Caspi. 2016. Animal Models of Ophthalmic Diseases. Animal Models of Ophthalmic Diseases
85
100
.
Gabriele Simonini, Andrea Taddio, Marco Cattalini, Roberto Caputo, Cinzia de Libero, Fulvio Parentin, Ilaria Pagnini, Loredana Lepore & Rolando Cimaz. (2013) Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis. Pediatric Rheumatology 11:1.
Crossref
Crossref
G. Simonini, P. Paudyal, G. T. Jones, R. Cimaz & G. J. Macfarlane. (2012) Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology 52:5, pages 825-831.
Crossref
Crossref
Frank H.P. Lai, David T.L. Liu & Dennis S.C. Lam. (2013) Review of Intermediate Uveitis. Asia-Pacific Journal of Ophthalmology 2:6, pages 375-387.
Crossref
Crossref
Alexandra Wexler, Trond Sand & Tor B Elsås. (2012) Bilateral macular thickening in mild unilateral anterior uveitis: is HLA-B27 involved?. BMC Ophthalmology 12:1.
Crossref
Crossref
Keith Wroblewski, H. Nida Sen, Steven Yeh, Lisa Faia, Zhuging Li, Pushpa Sran, Sapna Gangaputra, Susan Vitale, Patti Sherry & Robert Nussenblatt. (2011) Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease. Canadian Journal of Ophthalmology 46:4, pages 322-328.
Crossref
Crossref
Gabriele Simonini, Andrea Taddio, Marco Cattalini, Roberto Caputo, Cinzia De Libero, Samuele Naviglio, Cecilia Bresci, Monica Lorusso, Loredana Lepore & Rolando Cimaz. (2011) Prevention of flare recurrences in childhood‐refractory chronic uveitis: An open‐label comparative study of adalimumab versus infliximab. Arthritis Care & Research 63:4, pages 612-618.
Crossref
Crossref
Gabriele Simonini, Luca Cantarini, Cecilia Bresci, Monica Lorusso, Mauro Galeazzi & Rolando Cimaz. (2010) Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmunity Reviews 9:10, pages 674-683.
Crossref
Crossref